DE69331833D1 - Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose - Google Patents
Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporoseInfo
- Publication number
- DE69331833D1 DE69331833D1 DE69331833T DE69331833T DE69331833D1 DE 69331833 D1 DE69331833 D1 DE 69331833D1 DE 69331833 T DE69331833 T DE 69331833T DE 69331833 T DE69331833 T DE 69331833T DE 69331833 D1 DE69331833 D1 DE 69331833D1
- Authority
- DE
- Germany
- Prior art keywords
- glycosides
- vitamin
- treating
- preventing osteoporosis
- osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99795192A | 1992-12-29 | 1992-12-29 | |
PCT/US1993/012506 WO1994014411A1 (en) | 1992-12-29 | 1993-12-22 | Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69331833D1 true DE69331833D1 (de) | 2002-05-23 |
DE69331833T2 DE69331833T2 (de) | 2002-11-14 |
Family
ID=25544594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69331833T Expired - Fee Related DE69331833T2 (de) | 1992-12-29 | 1993-12-22 | Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose |
Country Status (9)
Country | Link |
---|---|
US (1) | US5508392A (de) |
EP (1) | EP0676951B1 (de) |
JP (1) | JPH08505147A (de) |
AU (1) | AU5853894A (de) |
CA (1) | CA2152163A1 (de) |
DE (1) | DE69331833T2 (de) |
DK (1) | DK0676951T3 (de) |
ES (1) | ES2173911T3 (de) |
WO (1) | WO1994014411A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2246234T3 (es) | 1999-05-04 | 2006-02-16 | Strakan International Limited | Glicosidos de androgenos y actividad androgenica de los mismos. |
AU7674000A (en) * | 1999-10-08 | 2001-04-23 | Strakan Group Plc | Tamoxifen and tamoxifen analogue glycosides and uses thereof |
WO2001027129A1 (en) * | 1999-10-08 | 2001-04-19 | Strakan Limited | Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof |
US7217696B2 (en) | 2002-02-28 | 2007-05-15 | A & D Bioscience, Inc. | Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof |
WO2003079980A2 (en) * | 2002-03-19 | 2003-10-02 | A & D Bioscience, Inc. | Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof |
US20050255038A1 (en) * | 2002-04-12 | 2005-11-17 | A And D Bioscience, Inc. | Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
EP1549323A2 (de) * | 2002-05-07 | 2005-07-06 | A & D Bioscience, Inc. | Konjugate mit einem wirkstoff für das zentrale nervensystem |
US20050215487A1 (en) * | 2002-06-27 | 2005-09-29 | Holick Michael F | Conjugates comprising an nsaid and a sugar and uses thereof |
US8465781B2 (en) * | 2008-04-21 | 2013-06-18 | Herbonis Ag | Preparation and use of a plant extract from Solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3 glycosides and quercetin glycosides |
EP2393494A1 (de) * | 2009-01-27 | 2011-12-14 | Berg Biosystems, LLC | Vitamin d3 und seine analoga zur linderung der nebenwirkungen einer chemotherapie |
CA2770683C (en) | 2009-08-14 | 2018-09-04 | Berg Biosystems, Llc | Vitamin d3 and analogs thereof for treating alopecia |
AU2010309784B2 (en) * | 2009-10-20 | 2016-11-10 | Herbonis Ag | Composition comprising Solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels |
SG10201709894RA (en) | 2013-05-29 | 2018-01-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4410515A (en) * | 1981-04-01 | 1983-10-18 | Massachusetts General Hospital | Vitamin D glycosides and a method of use |
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
US4772467A (en) * | 1985-02-19 | 1988-09-20 | Board Of Regents, U T Systems | Osteoporosis inhibition by dietary calcium supplementation |
US4740364A (en) * | 1985-09-27 | 1988-04-26 | Eastern Virginia Medical Authority | Predicting predisposition to osteoporosis |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
CA2010982C (en) * | 1989-02-28 | 2000-06-13 | Toshio Matsumoto | Osteogenesis promotion with use of vitamin d derivatives |
JPH05503922A (ja) * | 1989-10-04 | 1993-06-24 | トラスティーズ・オブ・ボストン・ユニバーシティー | 創傷及び潰瘍の治癒の促進並びに歯周病の処置方法 |
US5116828A (en) * | 1989-10-26 | 1992-05-26 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of osteoporosis |
US5013728A (en) * | 1990-05-04 | 1991-05-07 | Colgate - Palmolive Company | Composition for treating osteoporosis and hormonal imbalance |
US5194248A (en) * | 1990-06-21 | 1993-03-16 | Trustees Of Boston University | Compositions comprising vitamin D analog precursors and the use thereof |
US5167953A (en) * | 1990-06-21 | 1992-12-01 | Trustees Of Boston University | Compositions comprising tachysteral and the use thereof to provide vitamin D |
-
1993
- 1993-12-22 DE DE69331833T patent/DE69331833T2/de not_active Expired - Fee Related
- 1993-12-22 EP EP94904520A patent/EP0676951B1/de not_active Expired - Lifetime
- 1993-12-22 AU AU58538/94A patent/AU5853894A/en not_active Abandoned
- 1993-12-22 ES ES94904520T patent/ES2173911T3/es not_active Expired - Lifetime
- 1993-12-22 CA CA002152163A patent/CA2152163A1/en not_active Abandoned
- 1993-12-22 WO PCT/US1993/012506 patent/WO1994014411A1/en active IP Right Grant
- 1993-12-22 DK DK94904520T patent/DK0676951T3/da active
- 1993-12-22 JP JP6515425A patent/JPH08505147A/ja active Pending
-
1994
- 1994-04-20 US US08/230,867 patent/US5508392A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0676951A1 (de) | 1995-10-18 |
EP0676951A4 (de) | 1997-08-06 |
WO1994014411A1 (en) | 1994-07-07 |
DK0676951T3 (da) | 2002-06-03 |
EP0676951B1 (de) | 2002-04-17 |
DE69331833T2 (de) | 2002-11-14 |
ES2173911T3 (es) | 2002-11-01 |
US5508392A (en) | 1996-04-16 |
AU5853894A (en) | 1994-07-19 |
JPH08505147A (ja) | 1996-06-04 |
CA2152163A1 (en) | 1994-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE384703T1 (de) | Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen | |
DE69033509T2 (de) | Laserverfahren zur Behandlung von Mikrokapseln oder Teilchen | |
DE69434672D1 (de) | Verfahren zur behandlung von hühnereiern | |
DE3584013D1 (de) | Zubereitung zur behandlung von psoriasis. | |
DE3677400D1 (de) | Verfahren zur behandlung von knochenersatz-implantaten. | |
DE69115921D1 (de) | Verfahren zur behandlung und verwendung von abfallstoffen | |
DE69527140D1 (de) | Wirkstoff zur prävention oder behandlung von osteoporose | |
DE69331833D1 (de) | Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose | |
DE69526935D1 (de) | Verwendung von mycobacterium zur tumorbehandlung | |
ATA902789A (de) | Verfahren zur katalytischen behandlung von abwasser | |
DE59707519D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
DE3681642D1 (de) | Benzopyran-verbindungen zur behandlung von inkontinenz. | |
DE59209268D1 (de) | Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen | |
DE69328615T2 (de) | Verfahren zur behandlung von viehhaltungsgülle | |
DE69621447D1 (de) | Verwendung von nitroflavonoide zur behandlung von angstzuständen | |
DE59806627D1 (de) | Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen | |
DE3680507D1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
DE59705697D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
DE3856329D1 (de) | Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie | |
DE69701458T2 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
DE3586420D1 (de) | Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. | |
DE68907569D1 (de) | Mittel zur behandlung oder vorbeugung von aids. | |
DE69430545T2 (de) | Verwendung von penciclovir zur behandlung von postherpetischer neuralgie | |
DE59305800D1 (de) | Werkzeug zur behandlung von oberflächen von bauteilen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |